Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 USD | +3.16% | -9.54% | +26.72% |
20/03 | North American Morning Briefing : Markets on Hold -2- | DJ |
19/03 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- MRSN Stock
- Revisions Mersana Therapeutics, Inc.